Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both.
about
Breast Milk and Solid Food Shaping Intestinal ImmunityEarly environmental exposures and intracellular Th1/Th2 cytokine profiles in 24-month-old children living in an agricultural areaImmune Components in Human Milk Are Associated with Early Infant Immunological Health Outcomes: A Prospective Three-Country Analysis.Academy of Breastfeeding Medicine founder's lecture 2008: breastfeeding--an extrauterine link between mother and child.Altered monocyte activation markers in Tourette's syndrome: a case-control studyConsumption of omega3-fatty acids during perinatal life: role in immuno-modulation and allergy prevention.Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease.The early life origins of asthma and related allergic disorders.Mechanisms of allergic disease - environmental and genetic determinants for the development of allergy.Dietary prevention of allergic diseases in infants and small children. Part I: immunologic background and criteria for hypoallergenicity.In search for predictive factors for atopy in human cord blood.Renal CD14 expression correlates with the progression of cystic kidney diseaseColostrum and Mature Human Milk of Women from London, Moscow, and Verona: Determinants of Immune Composition.A systematic review of CD14 and toll-like receptors in relation to asthma in Caucasian children.Exclusive or Partial Breastfeeding for 6 Months Is Associated With Reduced Milk Sensitization and Risk of Eczema in Early Childhood: The PATCH Birth Cohort StudyAllergy Takes Its Toll: The Role of Toll-like Receptors in Allergy PathogenesisAntimicrobial peptides, skin infections, and atopic dermatitisClinical use of probiotics in the pediatric population.Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates.Immune markers in breast milk and fetal and maternal body fluids: a systematic review of perinatal concentrations.Factors affecting breast milk composition and potential consequences for development of the allergic phenotype.Does allergy begin in utero?Human Milk and Allergic Diseases: An Unsolved Puzzle.Role of Maternal Allergy on Immune Markers in Colostrum and Secretory Immunoglobulin A in Stools of Breastfed Infants.Food allergy in irritable bowel syndrome: new facts and old fallacies.Ingested soluble CD14 from milk is transferred intact into the blood of newborn rats.The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition.Estimation of sCD14 levels in saliva obtained from patients with various periodontal conditions.Brief case series: montelukast, at doses recommended for asthma treatment, reduces disease severity and increases soluble CD14 in children with atopic dermatitis.Interaction between ambient pollutant exposure, CD14 (-159) polymorphism and respiratory outcomes among children in Kwazulu-Natal, Durban.Reduced levels of soluble CD14 in atopic children.The differential effect of genetic variation on soluble CD14 levels in human plasma and milk.High breast milk IL-1β level is associated with reduced risk of childhood eczema.Relationship between breast milk sCD14, TGF-β1 and total IgA in the first month and development of eczema during infancy.Pregnancy, but not the allergic status, influences spontaneous and induced interleukin-1beta (IL-1beta), IL-6, IL-10 and IL-12 responsesEquine colostral carbohydrates reduce lipopolysaccharide-induced inflammatory responses in equine peripheral blood mononuclear cellsContribution of early nutrition on the development of malnutrition and allergic diseases in the first year of life: a study protocol for the Mother and Infant Cohort Study (MICOS)Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort studySoluble CD14 at 2 yr of age: Gender-related effects of tobacco smoke exposure, recurrent infections and atopic diseasesLactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial
P2860
Q26782801-41B3F423-1AD6-494D-A9FD-E5CEF5280911Q28394872-CDAE0667-21E4-4BFC-BDA5-6458F2822B6EQ33851756-8A3D97DC-7911-408F-BE41-F4C9CAFE021DQ34100166-BB823B97-6F6B-454B-9A30-9DC55496486AQ34218306-8AC14464-74A0-4256-B396-F5CC996619FAQ34575628-88AF1EDA-7245-4FAA-A15D-04B91AC5BCEBQ35030943-88DD1391-2B0D-4E7D-945D-D16828EE1100Q35278282-C4495C0E-12A7-44C6-A010-C9349B50DDDAQ35577604-D5C7483F-31BD-4188-BB40-B24404511722Q35732142-D8DA4B20-B974-462B-8663-21EBB4AC44BEQ36117559-A3FFB2DE-658C-410F-AC96-71129A085B24Q36172922-5952973E-7DEA-4F5E-9D66-8172DDA16906Q36186516-AFFD0755-E448-4905-AD32-629361D4228EQ36698136-C184C236-0E87-42B6-BB36-96BF44AA663FQ36822528-C7515CB1-B7A7-4D72-B979-21CDB445EF27Q36834302-E81B697A-7F51-4D8E-9E7F-7E2CFDD8D0F6Q37213664-4046D00B-E450-4CAC-B473-ABB5583957E2Q37401597-F586EBA6-10FF-414A-8779-86DBA0CD33CDQ37712058-73412189-C676-4990-BD82-7A3C11252FBAQ37890339-313A700E-B703-4912-9360-ACCEA2116B42Q38235436-0029F76D-D08F-4717-A381-2D9D63DA2B66Q38502907-5B8954C7-532A-42CD-8442-1894DA9B29FFQ38620244-03F0774E-6458-493D-BD1C-B6C62CA68DE5Q41071518-D3387871-8AF2-4A85-B18E-DDD006DC6FE4Q42037650-C3F86CBB-056A-47BC-9938-B28DA3FF92FBQ42395937-9B6F1802-22E5-4628-9D85-EF7586365F76Q45009823-B4732868-FA2D-4F2F-BAD4-22D23EFA9290Q45908855-FA79B20E-2612-4197-B4FB-5DAC9F9E2F67Q46493414-72EB45F0-2767-4CFF-9E12-D1C20820451CQ46816999-EF3E154E-D5B2-4CB3-9191-ED5D260D9700Q47776450-2818E772-A6E6-4DDD-A48C-AC61AB5C03FEQ47925793-4716E528-1EDD-44D2-B47D-900F66882725Q50634605-E7D9F4AA-D967-4603-935F-3EE635CF57C7Q51074466-AC3A363D-4C17-4DD9-B33F-F4B0954B735CQ56827901-65DC1D20-E0DB-4FA2-ACD9-E429A043DA0FQ56880675-43FC2150-09B5-43F4-BDD6-D2F0EDB4773FQ57175447-6F7911C4-2B07-45EA-B47C-AD009371445BQ57192511-68BD4744-B207-41C3-A14E-89464A77A034Q57708025-26DD7F7B-267A-4322-8A3A-2141B499A9C4Q57776939-B58DC4CD-6A74-4A89-8D85-C9EC1258B428
P2860
Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Reduced soluble CD14 levels in ...... ent of atopy, eczema, or both.
@en
Reduced soluble CD14 levels in ...... ent of atopy, eczema, or both.
@nl
type
label
Reduced soluble CD14 levels in ...... ent of atopy, eczema, or both.
@en
Reduced soluble CD14 levels in ...... ent of atopy, eczema, or both.
@nl
prefLabel
Reduced soluble CD14 levels in ...... ent of atopy, eczema, or both.
@en
Reduced soluble CD14 levels in ...... ent of atopy, eczema, or both.
@nl
P2093
P356
P1476
Reduced soluble CD14 levels in ...... ent of atopy, eczema, or both.
@en
P2093
Catherine A Jones
Eleanor J Popplewell
Gillian H s Vance
Jill A Warner
John O Warner
Norma D Diaper
P304
P356
10.1067/MAI.2002.123535
P407
P577
2002-05-01T00:00:00Z